Peter Hulick to Biological Specimen Banks
This is a "connection" page, showing publications Peter Hulick has written about Biological Specimen Banks.
Connection Strength
0.315
-
Validation of GenProb-T1D and its clinical utility for differentiating types of diabetes in a biobank from a US healthcare system. J Diabetes Investig. 2025 Jan; 16(1):10-15.
Score: 0.228
-
Cystic fibrosis F508del carriers and cancer risk: Results from the UK Biobank. Int J Cancer. 2021 04 01; 148(7):1658-1664.
Score: 0.044
-
Germline HOXB13 G84E mutation carriers and risk to twenty common types of cancer: results from the UK Biobank. Br J Cancer. 2020 10; 123(9):1356-1359.
Score: 0.043